DEA Removes 6-Beta-Naltrexol From Controlled Substances List

The Drug Enforcement Administration is removing the opioid antagonist 6-beta-naltrexol from schedule II of the Controlled Substances Act, it said in a final rule. Effective Jan. 24, DEA is removing “regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle” 6-beta-naltrexol, it said.